← FDA DRUG APPROVALS

FDA ANDA · ANDA202975

DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA202975
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-20
LATEST ACTION
2015-11-20
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDEDiscontinued
DUTASTERIDE 0.5MG, TAMSULOSIN HYDROCHLORIDE 0.4MG · CAPSULE · ORAL

Approval history

2015-11-20UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →